The Palico Private Equity Fund Marketplace
CTI Life Sciences Fund is a closed private equity fund managed by CTI Life Sciences.
Biopharmaceutical company SutroVax has raised $60m in Series B from Frazier Healthcare Partners, Pivotal bioVenture Partners and others.
Canada-based medical device company CellAegis Devices has closed a $9.5m Series C round from CTI Life Sciences Fund and others.
Vancouver-based PHEMI, a big data warehouse company, has raised C$12.2m led by CTI Life Sciences and others.
Read more news concerning CTI Life Sciences Fund
CTI Life Sciences is a private equity general partner firm headquartered in Montréal, Québec, Canada.
View full profile
Registration is fast, free and easy
Already a member?